HomeInsightsStock Comparison

Cohance Lifesciences Ltd vs Kwality Pharmaceuticals Ltd Stock Comparison

Cohance Lifesciences Ltd vs Kwality Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 980.4 as of 01 Aug 15:30.
  • The P/E Ratio of Cohance Lifesciences Ltd changed from 8.1 on March 2020 to 57.3 on March 2024 . This represents a CAGR of 47.89% over 5 yearsThe P/E Ratio of Kwality Pharmaceuticals Ltd changed from 3.2 on March 2020 to 17.9 on March 2024 . This represents a CAGR of 41.10% over 5 years.
  • The Market Cap of Cohance Lifesciences Ltd changed from ₹ 2564 crore on March 2020 to ₹ 17223 crore on March 2024 . This represents a CAGR of 46.37% over 5 yearsThe Market Cap of Kwality Pharmaceuticals Ltd changed from ₹ 26.51 crore on March 2020 to ₹ 424.8 crore on March 2024 . This represents a CAGR of 74.16% over 5 years.
  • The revenue of Cohance Lifesciences Ltd for the Mar '25 is ₹ 412.59 crore as compare to the Dec '24 revenue of ₹ 322.86 crore. This represent the growth of 27.79% The revenue of Kwality Pharmaceuticals Ltd for the Mar '25 is ₹ 116.44 crore as compare to the Dec '24 revenue of ₹ 85.06 crore. This represent the growth of 36.89%.
  • The ebitda of Cohance Lifesciences Ltd for the Mar '25 is ₹ 84.13 crore as compare to the Dec '24 ebitda of ₹ 133.41 crore. This represent the decline of -36.94% The ebitda of Kwality Pharmaceuticals Ltd for the Mar '25 is ₹ 26.65 crore as compare to the Dec '24 ebitda of ₹ 18.15 crore. This represent the growth of 46.83%.
  • The net profit of Cohance Lifesciences Ltd changed from ₹ 120.59 crore to ₹ 38.73 crore over 8 quarters. This represents a CAGR of -43.33% The net profit of Kwality Pharmaceuticals Ltd changed from ₹ 5.4 crore to ₹ 14.48 crore over 8 quarters. This represents a CAGR of 63.75% .
  • The Dividend Payout of Cohance Lifesciences Ltd changed from 23.57 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Kwality Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Suven Pharmaceuticals Ltd

  • Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
  • The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
  • The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles.

About Kwality Pharmaceuticals Ltd

  • Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics.
  • With little background of finished pharmaceuticals and high held spirits and will, he started this business.
  • He received his first drug license in 1981 approved for liquid oral manufacturing.
  • Presently, the Company has 48 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables.
  • The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce.

Cohance Lifesciences Ltd News Hub

News

Cohance Lifesciences appoints Yann D'Herve as CEO - CDMO Business

The Board of Cohance Lifesciences has appointed Yann D'Herve as Chief Executive Officer - ...

Read more

28 Jul 2025 18:56

News

Cohance Lifesciences announces resignation of CEO

Cohance Lifesciences announced the resignation of Dr. Sudhir Kumar Singh, who looks after ...

Read more

28 Jul 2025 18:52

News

Cohance Lifesciences to announce Quarterly Result

Cohance Lifesciences will hold a meeting of the Board of Directors of the Company on 13 Au...

Read more

28 Jun 2025 09:56

News

Cohance Lifesciences to hold AGM

Cohance Lifesciences announced that the 7th Annual General Meeting(AGM) of the company wil...

Read more

27 Jun 2025 15:41

News

Cohance Lifesciences' API Unit-IV clears USFDA inspection

Cohance Lifesciences has received the Establishment Inspection Report (EIR) from the Unite...

Read more

26 May 2025 08:46

News

Suven Pharmaceuticals allots 12.80 cr equity shares

Suven Pharmaceuticals has allotted 12,80,02,184 equity shares of the Company of face value...

Read more

09 May 2025 09:58

Kwality Pharmaceuticals Ltd News Hub

News

Kwality Pharma spurts on strong Q4 numbers

Sequentially, the company's consolidated net profit surged 69.87% while net sales jumped 3...

Read more

20 May 2025 16:17

News

Kwality Pharmaceuticals to declare Quarterly Results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 19...

Read more

08 May 2025 11:18

News

Kwality Pharmaceuticals announces board meeting date

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 19...

Read more

07 May 2025 11:33

News

Kwality Pharmaceuticals to discuss results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 31...

Read more

21 Jan 2025 11:06

News

Kwality Pharmaceuticals update on pre-clinical studies of Erythropoietin

Kwality Pharmaceuticals (KPL) has secured approval from the Review Committee on Genetic Ma...

Read more

02 Jan 2025 15:37

News

Kwality Pharma gains on securing RCGM approval for Erythropoietin

Erythropoietin is a critical therapeutic used to treat anemia associated with chronic kidn...

Read more

02 Jan 2025 14:28

SWOT Analysis Of Kwality Pharmaceuticals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Cohance Lifesciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Kwality Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Suven Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Cohance Lifesciences Ltd and Kwality Pharmaceuticals Ltd

Which company has a larger market capitalization, Cohance Lifesciences Ltd or Kwality Pharmaceuticals Ltd?

Market cap of Cohance Lifesciences Ltd is 37,506 Cr while Market cap of Kwality Pharmaceuticals Ltd is 1,166 Cr

What are the key factors driving the stock performance of Cohance Lifesciences Ltd and Kwality Pharmaceuticals Ltd?

The stock performance of Cohance Lifesciences Ltd and Kwality Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cohance Lifesciences Ltd and Kwality Pharmaceuticals Ltd?

As of August 2, 2025, the Cohance Lifesciences Ltd stock price is INR ₹980.4. On the other hand, Kwality Pharmaceuticals Ltd stock price is INR ₹1124.45.

How do dividend payouts of Cohance Lifesciences Ltd and Kwality Pharmaceuticals Ltd compare?

To compare the dividend payouts of Cohance Lifesciences Ltd and Kwality Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions